Literature DB >> 23677757

Role of F18-FDG-PET/CT in restaging patients affected by renal carcinoma.

Francesco Bertagna1, Federica Motta, Mattia Bertoli, Giovanni Bosio, Simona Fisogni, Regina Tardanico, Vittorio Ferrari, Alessandro Antonelli, Claudio Simeone, Sergio Cosciani Cunico, Raffaele Giubbini.   

Abstract

BACKGROUND: Renalcancers account for around 3% of all cancers and the most common type of (90%) is renal cell carcinoma Five-year survival rate in renal cancer patients is 68.4%. AIM: The aim of our study was to establish the role of F18-FDG-PET/CT in restaging patients with renal carcinoma who underwent partial or radical nephrectomy. Secondary aim of the study was to identify histological characteristics of the primary tumour that may be responsible for the metabolic behaviour of neoplastic lesions.
MATERIALS AND METHODS: We retrospectively evaluated 68 patients with renal carcinoma in whom F18-FDG-PET/CT was performed.
RESULTS: Sensitivity, specificity, positive predictive value, negative predictive value and accuracy of F18-FDG PET/CT were 82%, 100%, 100%, 66.7% and 86.8%, respectively.
CONCLUSIONS: The results of our study suggest that F18-FDG PET/CT is characterised by high specificity and positive predictive value and can be useful in restaging patients affected by renal carcinoma. However, due to low negative predictive value, this method cannot be recommended for definitely ruling out suspected disease relapse.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677757     DOI: 10.5603/NMR.2013.0002

Source DB:  PubMed          Journal:  Nucl Med Rev Cent East Eur        ISSN: 1506-9680


  13 in total

Review 1.  Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.

Authors:  Vidhya Karivedu; Amit L Jain; Thomas J Eluvathingal; Abhinav Sidana
Journal:  Curr Urol Rep       Date:  2019-08-29       Impact factor: 3.092

Review 2.  Advances in medical imaging for the diagnosis and management of common genitourinary cancers.

Authors:  Mohammad H Bagheri; Mark A Ahlman; Liza Lindenberg; Baris Turkbey; Jeffrey Lin; Ali Cahid Civelek; Ashkan A Malayeri; Piyush K Agarwal; Peter L Choyke; Les R Folio; Andrea B Apolo
Journal:  Urol Oncol       Date:  2017-05-12       Impact factor: 3.498

3.  (18)F-fluorodeoxyglucose-positron-emission tomography/computed tomography staging of mucinous tubular and spindle cell carcinoma of the kidney.

Authors:  Hakan Ozturk
Journal:  Indian J Nucl Med       Date:  2015 Jan-Mar

Review 4.  Molecular imaging of urogenital diseases.

Authors:  Steve Y Cho; Zsolt Szabo
Journal:  Semin Nucl Med       Date:  2014-03       Impact factor: 4.446

5.  Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma.

Authors:  Reiko Nakajima; Koichiro Abe; Tsunenori Kondo; Kazunari Tanabe; Shuji Sakai
Journal:  Eur Radiol       Date:  2015-09-24       Impact factor: 5.315

6.  Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.

Authors:  Pierpaolo Alongi; Maria Picchio; Fabio Zattoni; Marianna Spallino; Luigi Gianolli; Giorgio Saladini; Laura Evangelista
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-14       Impact factor: 9.236

7.  Can Initial (18)F-FDG PET-CT Imaging Give Information on Metastasis in Patients with Primary Renal Cell Carcinoma?

Authors:  Haejun Lee; Kyung Hoon Hwang; Seog Gyun Kim; Geon Koh; Ji Hyun Kim
Journal:  Nucl Med Mol Imaging       Date:  2013-11-28

8.  Postoperative distal ureteric and bladder cuff recurrence in a Grade I renal transitional cell carcinoma diagnosed and restaged by fluorodeoxyglucose positron emission tomography-computed tomography.

Authors:  Sunita Sonavane; Deepa Rani; Ramesh Asopa; Trupti Upadhye; Dilip Pawar
Journal:  Indian J Nucl Med       Date:  2014-10

9.  FDG-PET/CT and CT Findings of a Benign Solitary Fibrous Tumor of the Kidney; Correlation with Pathology.

Authors:  Reiko Nakajima; Koichiro Abe; Tsunenori Kondo; Yoji Nagashima; Ken Kimura; Kenji Fukushima; Mitsuru Momose; Chisato Kondo; Kazunari Tanabe; Shuji Sakai
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015

Review 10.  The Place of FDG PET/CT in Renal Cell Carcinoma: Value and Limitations.

Authors:  Yiyan Liu
Journal:  Front Oncol       Date:  2016-09-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.